Explore our resources by research/diagnostic specialty or content type
ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.
Salem, NH, October 12, 2021
[caption id="attachment_7170" align="alignleft" width="229"] Mollie Huber, Summer 2021 Diabetes Research Travel Grant Recipient[/caption]
FOR IMMEDIATE RELEASE – ALPCO’s Summer 2021 Diabetes Research Travel Grant has been awarded to Mollie Huber, a fourth year PhD candidate in the Biomedical Sciences program at the University of Florida.
Mollie’s novel resea...
We’re excited to announce that ALPCO will be exhibiting at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo at the Georgia World Congress Center in Atlanta, GA from September 28-30. We will be showcasing our growing menu of clinical test kits at booth 3431. Stop by to learn more about an exclusive AACC evaluation promotion for stool-based GI biomarker kits which includes two free...
Molecular GI testing for bacteria such as salmonella, vibrio, and E. coli, and viral pathogens including norovirus and rotavirus, is instrumental in the diagnosis and treatment of infection and dysbiosis. In addition, many gastrointestinal disorders often require protein biomarker tests to aid in accurate detection and diagnosis. ALPCO has worked with several clinical testing labs to incorporat...
Salem, NH, April 14, 2020
FOR IMMEDIATE RELEASE – Today ALPCO announced Xi Wang, a PhD candidate at Cornell University, as the latest recipient of its Diabetes Research Travel Grant.
Xi’s research focuses on the development of a transplantable encapsulation device for the safe delivery of functional, insulin-producing beta cells. She developed a tubular, Nanofiber Integrated Cell Encapsul...
While sending out for calprotectin testing offers some cost and convenience advantages when volumes are very low, bringing the process in-house allows for the opportunity to control costs, turnaround time, and quality. Considering costs and potential revenue, the volume at which in-house calprotectin testing makes sense may be lower than you think.
How to Increase Profitability with In-house C...
Salem, NH, April 14, 2020
FOR IMMEDIATE RELEASE – Today ALPCO announced Marlena Holter from Cornell University, College of Veterinary Medicine as the latest recipient of its Diabetes Research Travel Grant. Ms. Holter is a DVM/PhD candidate in the Biomedical and Biological Sciences Program researching GLP-1 regulated glucose regulation following vertical sleeve gastrectomy surgery to define t...
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test.
The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS.
FOR IMMEDIATE RELEASE - Salem, NH, October 29, 2019 -...
Salem, NH, September 23, 2019
FOR IMMEDIATE RELEASE - Today ALPCO announced that the latest recipient of its Young Investigator Award: The Diabetes Research Travel Grant is Daniel M. Tremmel from the University of Wisconsin. Mr. Tremmel is a PhD student in the Cellular and Molecular Biology Program researching methods to improve the 3D in vitro culture of stem cell derived beta cells for tra...
Today, multiple immunoassay platforms exist, providing scientists and clinicians with the means to measure a variety of biomarkers1,2,3. However, research indicates some immunoassay platforms have limitations that can inhibit progress in the laboratory4,5,6. In an effort to provide researchers with a tool to overcome some of these limitations, ALPCO developed its STELLUX® chemiluminescence immu...
February 5, 2019
ALPCO announced the latest recipient of its Young Investigator Award, the Diabetes Travel Grant. The grant was created to help advance progressive diabetes and obesity research by graduate students, postdoctoral fellows, and early stage investigators. The program seeks to stimulate and reward research applicable to the investigation and potential development of diabetes and ...
